BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 19, 2025
Home » Blogs » BioWorld MedTech Perspectives » Keeping up, staying connected

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

BioWorld MedTech

Keeping up, staying connected

Nov. 11, 2011
By Amanda Pedersen

Recently I posted a blog here about my observations of the medical device space over the last five years and how it has changed during my five-year tenure at Medical Device Daily. Like the industry, we too have changed a great deal since I joined the MDD staff in October 2006.

The first big change during that timeframe is the launching of Medical Device Daily Perspectives, our free, weekly e-zine, MDD Perspectives offering viewpoints on developments within the med-tech industry. In that, we aim to go beyond the news to provide you with a fresh outlook on the companies, trends, people and events taking place in the industry today. It goes beyond the who, what, where, when, how, and why to help you see understand how it affects you and why you should care.

Not long after MDD Perspectives launched, we saw an opportunity to bring you news as it is still developing, giving you a sneak peak at what to expect in our next daily issue of MDD. With that, the Medical Device Daily Midday Report was born. It's an email sent to our subscribers typically once a day (more in the event of late breaking news) offering a snippet of what we are working on for the next day’s issue. We figured we owed our subscribers that little heads-up on what to look for the following day.

As social networking has rapidly taken on a life of its own over the past couple of years, we knew we needed to engage our readers through sites like Facebook and Twitter in an effort to interact with you and also give you yet another venue of finding out what is happening at that very moment – tomorrow’s headlines today, so to speak, in 140 characters or less!

Earlier this year we launched the Medical Device Daily Perspectives Blog site. Similar to the weekly e-zine, this site brings you critical news, analysis, debates, commentary and camaraderie related to the med-tech industry.

We have worked hard over the last half a decade to keep up with the way information technology has changed and to deliver the news to you more immediately than ever before.

Of course there is always room for improvement and we do challenge ourselves on a regular basis to do better.

More blogs. More tweets. More breaking news alerts.

We’re always open to new ideas, so if there is something you would like to see more of, less of, or just think we should try doing differently, don’t be shy! Drop us an e-mail, Facebook message, Tweet to us, or simply post a comment here on our blog site.

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 18, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 18, 2025.
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • GLP-1 capsule

    Maintenance, man: Lilly’s phase III weight trial hits goals

    BioWorld
    Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing